|- Code of Conduct |- Fees |- Related Circular Letter    Bond Dealer and Underwriter |- Fees (section 14 and 19) |- Major Shareholders (section 90 and 91) |- Advertising (section 98(10)) |- Statutory

of Section 9, Paragraph 1 of Section 74 in conjunction with Section 28 and Paragraph 1 of Section 89 in conjunction with Section 28 of the Derivatives Act B.E. 2546 (2003), which contains certain

No. TorDor. 79/2552 Re: Rules, Conditions and Procedures for Filing of Annual Financial Statements and Preparation of Reports of the Stock Exchange of Thailand _____________ By virtue of Section 16/6

Company and its subsidiary for the fiscal year ended on 31 December 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical

the follow main reasons. 1. Revenue from hospital operations increased by Baht 102.22 million or 4.52 % due to in 2018 the general patients of Company and subsidiaries increased. 2. Cost of hospital

which were net loss of Baht 39.6 million. The operating results changed over 20%, main variances due to the following reasons: 1. Revenue from sales and services decrease from prior year by Baht 4.29

, due to the following reasons as follows; 1. Total incomes of the Company increase to 167.24 million baht equal to 240.37% against to the same period of last year mainly due to: 1.1) Revenue from Sales

million or 31.37% compared to the same period of last year of Baht 14.63 million, we wish to clarify the changes in our operating results as follows: ‐ Sales Revenue was increased by Baht 5.30 million or

and its subsidiary for Quarter 2 of 2018 ending on 30 June 2018 as follows; Statements of Comprehensive Income Revenue from Hospital Operations The Company generated the revenue from hospital operations

Company and its subsidiary for Quarter 3 of 2018 ending on 30 September 2018 as follows; Statements of Comprehensive Income Revenue from Hospital Operations The Company generated the revenue from hospital